vendredi 24 avril 2015

Onco Actu du 24 avril 2015

1. Biologie

Brain tumor growth driven by neuronal activity, Stanford-led study finds [Scope Blog]

4. Dépistage, diagnostic et pronostic

How a computer can help your doctor better diagnose cancer [MIT News]

5.12 Immunothérapies

'Personalised' cancer vaccine moves a step closer [The Independent]

5.2 Pharma

Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology [Xconomy]

Drug Companies Pin Hopes On TrialReach To Enroll Patients In Clinical Trials Faster [Forbes]

5.2.1 Pharma - Partenariats

MedImmune and Juno Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration [Juno Therapeutics]

AstraZeneca, Juno latest to collaborate on immuno-oncology drugs [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

Clovis Deal Chatter Heats Up Again as Goldman Says Buy: Real M&A [Bloomberg]

5.4 Traitements - Economie

Explainer: how does Keytruda treat melanoma and why is it so costly? [The Conversation]

5.9 AACR

What’s hot as one of cancer’s biggest events draws to a close for another year? [The Institute of Cancer Research]

5.9.4 AACR - poumon

AACR 2015: New Subsets of Lung Cancer With KRAS Gene Mutations Identified [The ASCO Post]

5.9.7 AACR - divers

The study that never existed: cancer edition [HealthNewsReview]

6.1 Observation

Study Forecasts New Breast Cancer Cases by 2030 [National Cancer Institute]

Ovary removal may improve breast cancer survival with gene mutation [Reuters]

6.6 Publications

Study: Peer Review Predicts Success [The Scientist]

Does peer review ferret out the best science? New study tries to answer [Retraction Watch]